Novartis AG Earnings Dividend

Novartis AG’s revenue fell -2.82% since last year same period to $14417.88Mn in the Q2 2026. On a quarterly growth basis, Novartis AG has generated 6.61% jump in its revenue since last 3-months.

Novartis AG’s net profit fell -19.17% since last year same period to $3266.24Mn in the Q2 2026. On a quarterly growth basis, Novartis AG has generated 3.49% jump in its net profits since last 3-months.

Novartis AG’s net profit margin fell -16.83% since last year same period to 22.65% in the Q2 2026. On a quarterly growth basis, Novartis AG has generated -2.92% fall in its net profit margins since last 3-months.

Novartis AG’s earning per share (EPS) estimates for the current quarter stand at 2.24 - a 1.82% jump from last quarter’s estimates.

Novartis AG’s earning per share (EPS) estimates for the current year stand at 2.24.

Novartis AG’s earning per share (EPS) fell -0.41% since last year same period to 2.41 in the Q2 2026. This indicates that the Novartis AG has generated -0.41% annual rate of fall in its earning per share (EPS) in the last 4 quarters.